β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02786654

Enrollment

179810

Registered

2016-06-01

Start date

2007-01-31

Completion date

2013-06-30

Last updated

2019-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Acute myocardial infarction, mortality, evidence-based care, Myocardial Ischaemia National Audit Project, β blockers

Brief summary

The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* acute myocardial infarction patients only * aged 18 to 100 years

Exclusion criteria

* other final diagnosis besides acute myocardial infarction * died in-hospital * patients with missing mortality data * aged \> 100 * patients with previous acute myocardial infarction or angina * patients who have received coronary interventions before * patients with heart failure * patients with β blocker prior use * patients contraindicated for β blocker use * patients with use of a loop diuretic

Design outcomes

Primary

Measure	Time frame
All cause mortality	1 year

Secondary

Measure	Time frame
All cause mortality	6 months

Countries

United Kingdom

Outcome results